Comparison between Astec Lifesciences Rights Issue 2025 and Kilitch Drugs (india) Rights Issue 2025.
Find important information like Listing Exchange, Terms of payment and Entitlement Ratio for Astec Lifesciences Rights Issue 2025 and Kilitch Drugs (india) Rights Issue 2025. Astec Lifesciences Rights Issue 2025 is listed on BSE, NSE while Kilitch Drugs (india) Rights Issue 2025 is listed on BSE, NSE.
| Astec Lifesciences Limited | Kilitch Drugs (india) Ltd. | |
|---|---|---|
| Logo | ![]() | ![]() |
| Listing At | BSE, NSE | BSE, NSE |
| Terms of Payment | Issue Price of Rs 890/- per share is payable at the time of Application in the Rights Issue. | The full amount of the Issue Price Rs 357/- will be payable on application. |
| Entitlement | 1 Rights Equity Share(s) for every 7 fully paid-up Equity Shares held on Record Date | 2 Rights Equity Share(s) for every 23 fully paid-up Equity Shares held on Record Date |
| Application Form | Application Form ![]() | Application Form ![]() |
| Letter of Offer | Letter of Offer ![]() | Letter of Offer ![]() |
| Registrar | MUFG Intime India Pvt.Ltd. | MUFG Intime India Pvt.Ltd. |
| Lead Managers |
The issue size of Astec Lifesciences Rights Issue 2025 rights issue is ₹249.35 Crores, whereas Kilitch Drugs (india) Rights Issue 2025 rights issue size is ₹49.93 Crores.
| Astec Lifesciences Limited | Kilitch Drugs (india) Ltd. | |
|---|---|---|
| Issue Size | 28,01,673 shares | 13,98,463 shares |
| Issue Size (Amount) | ₹249.35 Crores | ₹49.93 Crores |
| Issue Price | ₹890 per share | ₹357 per share |
| Face Value | ₹10 per share | ₹10 per share |
Find all the important dates related to the rights issue. The record date of Astec Lifesciences Rights Issue 2025 is Jul 04, 2025 while record date of Kilitch Drugs (india) Rights Issue 2025 is Jul 15, 2025.
| Astec Lifesciences Limited | Kilitch Drugs (india) Ltd. | |
|---|---|---|
| Record Date | Jul 04, 2025 | Jul 15, 2025 |
| Credit of Rights Entitlements | Jul 07, 2025 | Jul 16, 2025 |
| Bid/Offer Opens On | Jul 14, 2025 | Jul 23, 2025 |
| Renunciation of Rights Entitlements | Jul 22, 2025 | Aug 18, 2025 |
| Bid/Offer Closes On | Jul 28, 2025 | Aug 21, 2025 |
| Deemed Date of Allotment | Jul 29, 2025 | Aug 22, 2025 |
| Credit Date | Jul 30, 2025 | Aug 26, 2025 |
| Listing Date | Aug 01, 2025 | Aug 28, 2025 |
Comparison of Astec Lifesciences Rights Issue 2025 and Kilitch Drugs (india) Rights Issue 2025 financial data, including total revenue, PAT, and net worth. The table below also includes a list of all relevant documents like the Application Form and Letter of Offer. Related Parties like Lead Manager and Registrar are also mentioned in this section.
| Astec Lifesciences Limited | Kilitch Drugs (india) Ltd. | |||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financial | Astec Lifesciences Limited Financial Information (Restated Consolidated)Astec Lifesciences Limited's revenue decreased by 17% and profit after tax (PAT) dropped by 187% between the financial year ending with March 31, 2025 and March 31, 2024.
| Kilitch Drugs (india) Ltd. Financial Information (Restated Consolidated)Kilitch Drugs (india) Ltd.'s revenue increased by 28% and profit after tax (PAT) rose by 84% between the financial year ending with March 31, 2025 and March 31, 2024.
| ||||||||||||||||||||||||||||||||||||